An Epidemiologic Study of Patients Registered at COVID-19 Screening Centre and Analysis of Factors for Low Incidence of COVID-19 in a Tertiary Care Centre in New Delhi, India

International Journal of Medical Science
© 2020 by SSRG - IJMS Journal
Volume 7 Issue 5
Year of Publication : 2020
Authors : Priyanka Kundra, Sameeksha Jain, H.R.Singh, Neeta Wardhan, P.K.Dass, Dharmendra Kumar Basu
pdf
How to Cite?

Priyanka Kundra, Sameeksha Jain, H.R.Singh, Neeta Wardhan, P.K.Dass, Dharmendra Kumar Basu, "An Epidemiologic Study of Patients Registered at COVID-19 Screening Centre and Analysis of Factors for Low Incidence of COVID-19 in a Tertiary Care Centre in New Delhi, India," SSRG International Journal of Medical Science, vol. 7,  no. 5, pp. 11-14, 2020. Crossref, https://doi.org/10.14445/23939117/IJMS-V7I5P104

Abstract:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originated in Wuhan, China in December 2019 and has spread rapidly all over the world. The aim of this study is to describe the epidemiological profile and clinical presentation of the patients at the COVID-19 screening centre in a tertiary care hospital in central Delhi and to also analyse factors for low incidence of COVID -19 cases. It is a retrospective observational study of 371 patients who underwent testing as per current ICMR (Indian Council of Medical Research) guidelines where both nasopharyngeal and oropharyngeal swabs were taken for Reverse transcriptase – Polymerase Chain Reaction (RT-PCR) test. Clinical data including age, sex, travel history, contact history, symptoms and co-morbidities were collected. Mean age of patients was 34.88 years and males were more common (60.9%). The most common presentation of these patients was of upper respiratory tract infection (fever in 93% and cough in 89.8%). In tested patients, 79 patients (21.3%) gave the history of contact with laboratory confirmed COVID-19 patient and only 15 (4%) had a travel history outside India. Out of 371 patients whose sampling was done, 17 came out to be COVID-19positive. BCG vaccination may have reduced the number of cases in country.

Keywords:

SARS-CoV-2, Reverse transcriptase – Polymerase Chain Reaction, COVID-19, low, morbidity, mortality.

References:

[1] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506.
[2] Peiris JSM, Guan Y, Yuen KY. Severe acute respiratory syndrome. Nat Med 2004; 10 (suppl 12): S88–97.
[3] Coronavirus disease (COVID-19) pandemic. Geneva: World Health Organization (https://www.who.int/emergencies/diseases/novel-coronavirus-2019) [4] Mukesh R. "Coronavirus in India: Tracking country's first 50 COVID-19 cases; what numbers tell". IndiaToday. Retrieved 12 March2020.
[5] WHO. Novel coronavirus (2019-nCoV) situation report–3. Jan 23, 2020. https://www.who.int/docs/default-source/ coronaviruse/situation-reports/20200123-sitrep-3-2019-ncov.pdf
[6] Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020. doi: 10.1056/NEJMoa2002032.
[7] Indian Council For Medical Research(https://icmr.nic.in/content/covid-19)
[8] Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus. Susan R. Weiss, Sonia Navas-Martin. Microbiology and Molecular Biology Reviews Dec 2005, 69 (4) 635 664; DOI: 10.1128/MMBR.69.4.635-664.2005.
[9] Ministry of Health and Family Welfare, Government of India.(https://www.mohfw.gov.in/).
[10] Young BE, et al. Epidemiologic features and Clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020;323(15):1488-1494 doi:10.1001/jama.2020.3204.
[11] Miller A, Reandelar MJ, et al. Correlation between Universal BCG vaccinationpolicy and reduced morbidity and mortality for COVID-19: An Epidemiological Study. medRxiv preprint doi: https://doi.org/10.1101/2020.03.24.20042937.
[12] Rathi S, Ish P, Kalantri A, Kalantri S. Hydroxychloroquine prophylaxis for COVID-19 contacts in India. The Lancet Infectious Disease. Apr 17(2020) doi:10.1016/S1473-3099(20)30313-3.